{"version":"1.0","provider_name":"Pulmonx","provider_url":"https:\/\/pulmonx.com\/fr\/","author_name":"Pulmonx","author_url":"https:\/\/pulmonx.com\/fr\/","title":"\u00c0 propos de Pulmonx - Pulmonx","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"tLGX2Pxbjc\"><a href=\"https:\/\/pulmonx.com\/fr\/a-propos-de-pulmonx\/\">\u00c0 propos de Pulmonx<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/pulmonx.com\/fr\/a-propos-de-pulmonx\/embed\/#?secret=tLGX2Pxbjc\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0\u00c0 propos de Pulmonx\u00a0\u00bb &#8212; Pulmonx\" data-secret=\"tLGX2Pxbjc\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/pulmonx.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Leader mondial en mati\u00e8re de pneumologie interventionnelle, d&rsquo;outils de planification et de traitements des maladies pulmonaires obstructives. Bas\u00e9e \u00e0 Redwood City, en Californie, et \u00e0 Neuch\u00e2tel, en Suisse, Pulmonx est le fabricant de la valve endobronchique Zephyr. La valve Zephyr\u00ae a obtenu le statut de premier dispositif mini-invasif approuv\u00e9 par la FDA en juin 2018. [&hellip;]","thumbnail_url":"https:\/\/pulmonx.com\/wp-content\/uploads\/2019\/09\/COPD-Technology-Zephyr-Valve-200x209.png"}